About Haisco Pharmaceutical Group
Haisco Pharmaceutical Group is a company based in Chengdu (China) founded in 2009. The company has 5,340 employees as of December 31, 2024. Haisco Pharmaceutical Group offers products and services including Anesthesia Drugs and Oncology Drugs.
- Headquarter Chengdu, China
- Employees 5340 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Haisco Pharmaceutical Group Co. Ltd. Class A
-
Annual Revenue
$502.78 M (USD)11.14as on Dec 31, 2024
-
Net Profit
$54.18 M (USD)34as on Dec 31, 2024
-
EBITDA
$55.71 M (USD)-23.16as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
5340
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Haisco Pharmaceutical Group
Haisco Pharmaceutical Group is a publicly listed company on the SZSE with ticker symbol 002653 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Haisco Pharmaceutical Group
Haisco Pharmaceutical Group offers a comprehensive portfolio of products and services, including Anesthesia Drugs and Oncology Drugs.
Drugs for anesthesia and pain management are developed and supplied for medical use
Drugs related to tumors and antiemetics are researched and provided for treatment purposes
Funding Insights of Haisco Pharmaceutical Group
Detailed funding history for Haisco Pharmaceutical Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haisco Pharmaceutical Group
Investment portfolio details for Haisco Pharmaceutical Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haisco Pharmaceutical Group
Detailed financials for Haisco Pharmaceutical Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haisco Pharmaceutical Group Comparisons
Peer comparison for Haisco Pharmaceutical Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haisco Pharmaceutical Group
Detailed competitors of Haisco Pharmaceutical Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haisco Pharmaceutical Group
Complete news archive for Haisco Pharmaceutical Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haisco Pharmaceutical Group
Haisco Pharmaceutical Group was founded in 2009.
Haisco Pharmaceutical Group is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
As of Dec 31, 2024, the latest employee count at Haisco Pharmaceutical Group is 5,340.
Annual revenue of Haisco Pharmaceutical Group is $502.78M as on Dec 31, 2024.
Haisco Pharmaceutical Group was established in 2009 in Chengdu, China, within the pharmaceuticals sector. Drug development is conducted for areas such as anesthetic analgesics, endocrine system treatments, and oncology. A pipeline of new candidates is advanced, while the portfolio includes products for the nervous system, cardiovascular conditions, digestive and liver diseases, and mens health. Operations emphasize research to support market introduction of therapies.
Haisco Pharmaceutical Group offers Anesthesia Drugs and Oncology Drugs.
Yes, Haisco Pharmaceutical Group is publicly traded on SZSE under the ticker symbol 002653.
The ticker symbol of Haisco Pharmaceutical Group is 002653 on SZSE.